Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | PVLA | PHVS | ||
| Company | Akcea Therapeutics Inc | Palvella Therapeutics Inc | Pharvaris N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.15 | 126.04 | 26.77 | ||
| High | 18.17 | 131.01 | 28.00 | ||
| Low | 18.13 | 125.92 | 26.53 | ||
| Latest | 18.17 | 129.00 | 27.88 | ||
| Change | +0.03 | +1.88 | +1.25 | ||
| % Change | +0.17% | +1.48% | +4.69% | ||
| Volume | 815,300 | 178,100 | 417,300 | ||
| 20-Day Average Volume | 661,490 | 284,100 | 218,475 | ||
| Previous Close | 18.14 | 127.12 | 26.63 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 119.98 | 27.15 | ||
| 20-Day Raw Stochastic | 70.59% | 79.05% | 59.80% | ||
| 20-Day Relative Strength | 73.10 | 57.08 | 53.42 | ||
| Weighted Alpha | -23.90 | +232.41 | +65.99 | ||
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 8% Buy | 100% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +7.63% since 04/06/26 | -1.73% since 04/06/26 | ||
| Low | 18.08 on 10/05/20 | 112.83 on 04/07/26 | 26.00 on 04/10/26 | ||
| High | 18.17 on 10/09/20 | 134.01 on 04/09/26 | 29.36 on 04/07/26 | ||
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | +5.69% since 03/13/26 | +9.68% since 03/13/26 | ||
| Low | 18.05 on 09/21/20 | 108.63 on 03/30/26 | 24.95 on 03/24/26 | ||
| High | 18.22 on 09/28/20 | 134.40 on 03/16/26 | 29.85 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | +24.59% since 01/13/26 | +7.23% since 01/13/26 | ||
| Low | 9.81 on 08/05/20 | 72.22 on 01/30/26 | 24.51 on 01/16/26 | ||
| High | 19.65 on 08/31/20 | 151.18 on 02/26/26 | 29.85 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | +69.25% since 10/13/25 | +26.33% since 10/13/25 | ||
| Low | 9.81 on 08/05/20 | 68.96 on 10/28/25 | 20.65 on 10/17/25 | ||
| High | 19.65 on 08/31/20 | 151.18 on 02/26/26 | 29.85 on 04/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 1,846,506 | 1,823,575 | ||
| Shares Outstanding, K | 101,599 | 14,314 | 65,408 | ||
| Annual Sales | 488,540,000 | 0 | 0 | ||
| Annual Net Income | 40,770,000 | -41,720,000 | -198,790,000 | ||
| Last Quarter Sales | 22,380,000 | 0 | 0 | ||
| Last Quarter Net Income | -49,580,000 | -12,710,000 | -54,930,000 | ||
| 60-Month Beta | 1.45 | -0.21 | -2.58 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | -1.08 on 03/31/26 | -0.84 on 04/02/26 | ||
| Latest Earnings Date | 11/03/20 | 05/21/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||